Minerva Neurosciences (NERV) Tops Q2 EPS by 5c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• JPMorgan Reiterates Overweight Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
• UBS Starts Diagnosticos da America SA (DASA3:BZ) at Buy
• JPMorgan Starts NexGen Energy Ltd (NXE) at Overweight